Timing of adjuvant and neoadjuvant therapy in colorectal cancers.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical colorectal cancer

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3816/CCC.2010.n.019PMID 20643618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group

  2009cited by this paper
• Effects of oxaliplatin and 5-fluorouracil on the healing of colon anastomoses

  2009cited by this paper
• Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.

  2008cited by this paper
• Single‐institution experience of adjuvant 5‐fluorouracil‐based chemotherapy for stage III colon cancer

  2008cited by this paper
• Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.

  2008cited by this paper
• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

  2008cited by this paper
• Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer—a review focusing on open questions

  2008cited by this paper
• The Impact of Postoperative Complications on Long-Term Outcomes Following Curative Resection for Colorectal Cancer

  2007cited by this paper
• Impact of timing of initiation of adjuvant chemotherapy on survival after resection of colorectal cancer

  2007cited by this paper
• Histological evaluation of colonic anastomotic healing, during perioperative Capecitabine administration. Experimental study in rats.

  2007cited by this paper
• Delayed start of adjuvant 5-FU/leucovorin based chemotherapy in colon cancer is safe up to 12 weeks postoperatively

  2007cited by this paper
• Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

  2007cited by this paper
• Cancer: A medical emergency.

  2006cited by this paper
• Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

  2006cited by this paper
• Adjuvant therapy in colon cancer--what, when and how?

  2006cited by this paper
• Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

  2006cited by this paper
• Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy

  2005cited by this paper
• Explaining black-white differences in receipt of recommended colon cancer treatment.

  2005cited by this paper
• A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.

  2005cited by this paper
• early postoperative i ntraperitoneal chemotherapy

  2005cited by this paper
• Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases?

  2005cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.

  2003cited by this paper
• Effect of electromagnetic fields and early postoperative 5-fluorouracil on the healing of colonic anastomoses

  2003cited by this paper
• Adjuvant therapy of colon cancer.

  2001cited by this paper
• Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

  2001cited by this paper
• Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer.

  2001cited by this paper
• New directions in the treatment of colorectal cancer: a look to the future.

  2000cited by this paper
• Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

  1999cited by this paper
• Colonic anastomotic healing after preoperative chemo-radiotherapy in rat.

  1999cited by this paper
• Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer--too good to be true?

  1999cited by this paper
• Adjuvant regional chemotherapy after hepatic resection for colorectal metastases

  1999cited by this paper
• Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma.

  1999cited by this paper
• Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine?

  1999cited by this paper
• Immune surveillance against a solid tumor fails because of immunological ignorance.

  1999cited by this paper
• 5‐Fluorouracil‐induced small bowel toxicity in patients with colorectal carcinoma

  1999cited by this paper
• Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.

  1999cited by this paper
• Histological evaluation of colonic anastomotic healing in the rat following preoperative 5-fluorouracil, fractionated irradiation, and combined treatment

  1998cited by this paper
• Effects of early postoperative 5‐fluorouracil and ageing on the healing capacity of experimental intestinal anastomoses

  1998cited by this paper
• Immediate postoperative 5‐FU does not decrease colonic anastomotic strength

  1998cited by this paper
• A collective review of the world literature on hepatic cryotherapy.

  1998cited by this paper
• Distinct mechanisms of immunosuppression as a consequence of major surgery

  1997cited by this paper
• Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.

  1997cited by this paper
• Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

  1995cited by this paper
• The roles of nutritional depletion and drug concentration in 5-fluorouracil-induced inhibition of colonic healing.

  1994cited by this paper
• Early post-operative 5-fluorouracil does not affect the healing of experimental intestinal anastomoses

  1993cited by this paper
• Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing.

  1992cited by this paper
• Presence of a growth-stimulating factor in serum following primary tumor removal in mice.

  1989cited by this paper
• A Gompertzian model of human breast cancer growth.

  1988cited by this paper
• Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

  1983cited by this paper
• Early Post-operative Endoscopy of the Operated Intestine

  1981cited by this paper
• Effect of surgical removal on the growth and kinetics of residual tumor.

  1979cited by this paper
• Healing of experimental colonic anastomoses. II. Breaking strength of the colon after left colon resection and anastomosis.

  1978cited by this paper
• The use of drugs in combination for the treatment of cancer: rationale and results.

  1973cited by this paper
• HEALING OF COLONIC ANASTOMOSES IN THE RAT.

  1964cited by this paper

• Towards exertion of immunotherapeutics in the treatment of colorectal cancer; adverse sides, challenges, and future directions.

  2021cites this paper
• Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer

  2021cites this paper
• Nuclear translocation of ATG5 induces DNA mismatch repair deficiency (MMR‐D)/microsatellite instability (MSI) via interacting with Mis18α in colorectal cancer

  2021cites this paper
• Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy

  2020cites this paper
• High level of unmet needs and anxiety are associated with delayed initiation of adjuvant chemotherapy for colorectal cancer patients

  2020cites this paper
• Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).

  2019cites this paper
• Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration.

  2018cites this paper
• Age and factors associated with access and time to post-operative adjuvant chemotherapy in colon cancer: a French epidemiological study.

  2017cites this paper
• Erratum to: Prognostic Relevance of the Timing of Initiating and the Completion of Adjuvant Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma

  2017cites this paper
• Prognostic Relevance of the Timing of Initiating and the Completion of Adjuvant Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma

  2016cites this paper
• Adjuvant and palliative systemic treatment for colon cancer

  2016cites this paper
• Initiation of adjuvant chemotherapy within 8 weeks of elective colorectal resection improves overall survival regardless of reoperation

  2016cites this paper
• The impact of adjuvant chemotherapy timing on overall survival following colorectal cancer resection.

  2015cites this paper
• Optimal Time of Initiating Adjuvant Chemotherapy After Curative Surgery in Colorectal Cancer Patients

  2013cites this paper
• Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care.

  2013cites this paper